| News

Basel’s Lyfegen closes seed financing round

18.04.2019

Lyfegen, an IT company specializing in healthcare from Basel, has raised 750,000 Swiss francs in a seed financing round. The startup has developed a software solution to overcome technical hurdles in value-based healthcare.

The founding team of the Lyfegen HealthTech AG

Value-based healthcare puts the spotlight on the successful treatment of patients. This involves assessing the outcome of treatment as a whole, rather than focusing on the quantity of drugs prescribed or medical appointments. In Lyfevalue, Basel startup Lyfegen has developed a platform that enables life sciences companies, national and private healthcare payers and healthcare providers to execute value-based pricing contracts. Lyfegen has now successfully closed its seed financing round, led by Swiss private investors, raising a total of 750,000 francs, it was reported in a press release.

Founded in October 2018, Lyfegen HealthTech AG will use these funds to further build its platform and conduct new pilot projects with partners in Africa, the EU and the USA. Lyfegen will therefore offer a platform that allows healthcare providers to operationalize value-based healthcare strategies, while fostering accelerated and facilitated access to innovative treatments for patients. “Enabling the shift to sustainable healthcare is a huge challenge, giving us at Lyfegen great purpose,” said Girisha Fernando, Lyfegen’s CEO & Founder.

The founders – Michel Mohler, Nico Mros, Leon Rebolledo and James Gannon, in addition to Girisha Fernando – previously worked at companies including RocheNovartis and UBS. Subsequently, they created their software solution for Lyfegen to enter a market set to grow to US$390.7 billion by 2024, according to the press release. Lyfegen is accompanied and supported on its way by BaselArea.swiss.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Invest

Ricola earns the trust of Switzerland

Ricola has been voted the most trustworthy brand in Switzerland. The manufacturer of herbal candy, which is based in the Basel Area, previously won this award in 2017.

Read More
Basel Area Business & Innovation, Innovation

docdok.health involved in coronavirus research project

A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.

Read More
Basel Area Business & Innovation, Innovation

Celonic agrees cooperation to combat coronavirus

The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.

Read More
Basel Area Business & Innovation, Innovation, Invest

Idorsia receives payment of 45 million US dollars

The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..

Read More
Basel Area Business & Innovation, Innovation

Humard robot disinfects using UV light

Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.

Read More
Basel Area Business & Innovation, Innovation, Invest

Roche authorized to distribute coronavirus antibody tests

Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.

Read More
Basel Area Business & Innovation, Invest

Basel is the most popular Swiss location for headquarters

Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.

Read More
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Healthtech sector growing rapidly in the Basel Area

The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.

Read More
Basel Area Business & Innovation, Innovation, Invest

Support program has roots in Basel

The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.

Read More
Basel Area Business & Innovation, Innovation

University Hospital Basel treats coronavirus patients with plasma

The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.

Read More
1 2 3 18

Do you have a question? We'd like to hear from you.